Anett Ullrich
Papers
1
Total Citations
19
H-Index
1
About
Anett Ullrich is a pioneering researcher in microfluidic organ-on-chip technologies, with a primary focus on advanced liver models for drug testing and toxicology. Her most notable contribution is the development of the HepaChip-MP, a groundbreaking twenty-four chamber microplate that enables continuously perfused liver coculture. This innovative platform uses automated dielectrophoresis to selectively assemble viable cells into elongated microtissues, creating a more physiologically relevant environment for studying liver function. Her work has garnered significant attention, with her key publication accumulating 19 citations, reflecting its importance in the field of tissue engineering and preclinical drug screening. Ullrich's research addresses critical challenges in pharmaceutical development by providing more accurate in vitro models that can potentially reduce reliance on animal testing. Her achievements demonstrate a remarkable ability to bridge engineering principles with biological applications, making her work essential reading for students and researchers interested in microfluidics, liver biology, and the future of personalized medicine through organ-on-chip technologies.
Research Focus
Key Achievements
Top Papers
- 1